Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

18 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Phenergan Articles

US FDA finds potential signs of AERs in drugs including cancer and bowel agents

8 October 2009

US Supreme Court rules against Wyeth over FDA pre-emption

9 March 2009

US Supreme Court rules against Wyeth over FDA pre-emption

9 March 2009

FDA pre-emption case: "verdict in 2009"

10 November 2008

Landmark case at US Supreme Court

3 November 2008

FDA labeling rule upsets trial lawyers

1 September 2008

NEJM editors side against Wyeth

1 September 2008

Law suits stall awaiting FDA pre-emption verdict

18 August 2008

SCOTUS signals support for FDA pre-emption

3 March 2008

SCOTUS signals FDA pre-emption support

3 March 2008

FDA pre-emption case taken up by SCOTUS

28 January 2008

Indian Pharma cuts 886 drug prices

13 November 2006

Able gains FDA appro for generic promethazine

12 July 2004

Agis obtains FDA approval for Promethazine

7 July 2003

Baxter acquires ESI in $305M deal

6 January 2003

R-PR's Phenergan Recalled

9 April 1997

Showing 1-16 of 16 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS